The aim of the Fund is to provide a growing income with capital growth.
Name | % Net Assets |
---|---|
Vodafone Group PLC | 5.3% |
GlaxoSmithKline PLC | 4.5% |
Royal Dutch Shell PLC (CL B) | 4.3% |
BP PLC | 3.9% |
AstraZeneca PLC | 2.9% |
National Grid PLC | 2.7% |
British American Tobacco PLC | 2.6% |
Scottish & Southern Energy PLC | 2.5% |
Imperial Tobacco Group PLC | 2.3% |
RSA Insurance Group PLC | 2.0% |
Key | % Net Assets |
---|---|
Vodafone Group PLC | 5.3% |
GlaxoSmithKline PLC | 4.5% |
Royal Dutch Shell PLC (CL B) | 4.3% |
BP PLC | 3.9% |
Other | 82% |
Date | 09-Apr-2021 |
---|---|
Bid | 81.12p |
Offer | 81.12p |
Currency | GBP |
Change | 0.13p |
% | 0.16% |
YTD change | 81.12p |
YTD % | n/a |
Fund Inception | 26/08/1997 |
---|---|
Fund Manager | Chris White |
TER | - |
Minimum Investment | |
---|---|
Initial | £500000 |
Additional | n/a |
Savings | n/a |
Charges | |
---|---|
Initial | n/a |
Annual Mang't | 1.25% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.01 |
Sharpe ratio | 0.07 |
You are here: research